• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. SUTUREFIX ULTRA AHR XL 2 UB BLUE/WH; FASTENER, FIXATION, NONDEGRADABLE, SOFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. SUTUREFIX ULTRA AHR XL 2 UB BLUE/WH; FASTENER, FIXATION, NONDEGRADABLE, SOFT TISSUE Back to Search Results
Model Number 72203842
Medical Device Problem Code Break (1069)
Health Effect - Clinical Codes Failure of Implant (1924); Foreign Body In Patient (2687)
Date of Event 05/27/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Internal complaint reference case-(b)(4).
 
Event or Problem Description
It was reported that during a hip labrum suture surgery procedure, two suturefix ultra ahr xl 2 ub blue/wh broke during the implantation since the mechanism did not allow the anchors to be released.Procedure finished with two suturefix backup implants with no delay.The patient will be hospitalized again because there is a residual foreign body in her hip.
 
Additional Manufacturer Narrative
The reported device, used in treatment, was not returned to the designated complaint unit for independent evaluation, thus visual inspection and functional testing could not be performed.A review of the device history records showed there were no indications to suggest that the product did not meet manufacturing specification or would not be able to perform as intended.The instructions for use was reviewed and found to include conditions of off label use and technique specifics, as well as precautions and warnings related to the use of the device.A review of risk management files found that the reported failure was documented appropriately.A review of the material found there are requirements for conformance and a certificate of material analysis is required.A relationship, if any, between the subject device and the reported event could not be determined.Please refer to the instructions for use for recommendations on proper use of the device and potential troubleshooting methods to prevent future reoccurrence of the reported event.No containment or corrective actions are recommended at this time.If the product associated with this event is returned at a future date, this investigation will be reopened for evaluation.
 
Additional Manufacturer Narrative
H3, h6: part of the reported device was received for evaluation.A visual inspection found the device was returned without the suturefix anchor or suture and the button and trigger were actuated.The inserter tip fork was hidden within the shaft since the device had been actuated.A functional evaluation could not be performed as the device had already been actuated.Based on the condition of the product material found during visual inspection, additional material testing is not required.A review of device records showed there were no indications to suggest that the product did not meet manufacturing specifications upon release for distribution.A complaint history review found no similar reported events.The instructions for use were reviewed and found to include conditions of off label use and technique specifics, as well as precautions and warnings related to the use of the device.A risk management review found that the reported failure and/or harm was documented appropriately, and there were no indications to suggest the anticipated risk is not adequate.A review of the suture material specifications found a material certificate of analysis is required.A clinical review states if a portion of the anchor remains retained in the patient, it is made of a biocomposite material which is intended for implantation to allow for bone growth.The root cause could not be determined as the anchor/suture was not returned for analysis.Factors that may have contributed to the reported event include unintended excessive force on insertion or off-axial insertion.No containment or corrective actions are recommended at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUTUREFIX ULTRA AHR XL 2 UB BLUE/WH
Common Device Name
FASTENER, FIXATION, NONDEGRADABLE, SOFT TISSUE
Manufacturer (Section D)
SMITH & NEPHEW, INC.
130 forbes blvd.
mansfield MA 02048
Manufacturer (Section G)
SMITH & NEPHEW, INC.
130 forbes blvd.
mansfield MA 02048
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key12015851
Report Number1219602-2021-01381
Device Sequence Number14507971
Product Code MBI
UDI-Device Identifier00885554031553
UDI-Public00885554031553
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K122059
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 11/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/10/2025
Device Model Number72203842
Device Catalogue Number72203842
Device Lot Number2041448
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Received by Manufacturer 05/27/2021
Supplement Date Received by Manufacturer07/14/2021
11/22/2023
Initial Report FDA Received Date06/17/2021
Supplement Report FDA Received Date07/30/2021
11/28/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/10/2019
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-